pre-IPO PHARMA

COMPANY OVERVIEW

WindMIL is a clinical-stage biotechnology company developing a new class of cell therapy.


LOCATION

  • Baltimore, MD, USA

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    https://windmiltherapeutics.com/


    CAREER WEBSITE

    https://windmiltherapeutics.com/careers.html


    SOCIAL MEDIA


    INVESTORS

    domain-associates foxkiser qiming-venture-partners


    PRESS RELEASES


    May 6, 2021

    WindMIL Therapeutics Appoints Dr. Kimberly Noonan as Chief Science and Technology Officer


    Nov 9, 2020

    WindMIL Therapeutics Presents New Marrow-Infiltrating Lymphocytes (MILs) Data Demonstrating Broad Therapeutic Promise for Solid Tumor Cancers


    Oct 20, 2020

    WindMIL Therapeutics Announces Marrow-Infiltrating Lymphocytes (MILs) Data Selected for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting


    Oct 13, 2020

    WindMIL Therapeutics and Stephenson Cancer Center Announce Collaboration to Collect Bone Marrow from Patients with Renal and Urothelial Carcinomas to Develop Marrow Infiltrating Lymphocytes (MILs)


    Oct 5, 2020

    WindMIL Therapeutics to Present at 2020 Virtual Cell and Gene Meeting on the Mesa


    For More Press Releases


    Google Analytics Alternative